Jeil Pharma Holdings Inc (KRX:002620)
South Korea · Delayed Price · Currency is KRW 8,010.00
-100.00 (-1.23%)
Jan 9, 2026, 3:30 PM KST
Jeil Pharma Holdings Market Cap
Jeil Pharma Holdings has a market cap or net worth of 122.96 billion as of January 9, 2026. Its market cap has increased by 4.43% in one year.
Market Cap
122.96B
Enterprise Value
362.79B
Revenue
707.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,010.00
Market Cap Chart
Since August 30, 1995, Jeil Pharma Holdings's market cap has increased from 26.30B to 122.96B, an increase of 367.61%. That is a compound annual growth rate of 5.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 122.96B | -0.37% |
| Dec 30, 2025 | 123.42B | 2.81% |
| Dec 30, 2024 | 120.05B | -33.56% |
| Dec 28, 2023 | 180.68B | -23.57% |
| Dec 29, 2022 | 236.41B | -3.75% |
| Dec 30, 2021 | 245.62B | -24.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 81.80T |
| Celltrion | 46.17T |
| ALTEOGEN | 25.19T |
| ABL Bio | 11.60T |
| SK Biopharmaceuticals | 9.76T |
| Yuhan | 8.45T |
| HLB Co., Ltd. | 7.15T |
| LigaChem Biosciences | 6.51T |